SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative Review

SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative Review

Canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin belong to a class of antidiabetic treatments referred to as sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors, or SGLT2is). SGLT2is are currently indicated in North America and in Europe in type 2 diabetes mellitus, especially...

Full description

Bibliographic Details
Main Authors: Henri Lu, Hortense Lu, Christophe Kosinski, Anne Wojtusciszyn, Anne Zanchi, Pierre-Nicolas Carron, Martin Müller, Philippe Meyer, Jehan Martin, Olivier Muller, Roger Hullin
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
diabetes
heart failure
renal
guidelines
Online Access:https://www.mdpi.com/2077-0383/10/9/2036

Internet

https://www.mdpi.com/2077-0383/10/9/2036

Similar Items